Advertisement
 

doctorslounge.com

 
Powered by
Careerbuilder

 

                    Home  |  Forums  |  Humor  |  Advertising  |  Contact
   Ask a Doctor

   News via RSS

   Newsletter

   Fertility

   News

 

 Conferences


   CME

   Forum Archives

   Diseases

   Symptoms

   Labs

   Procedures

   Drugs

   Links
   Specialties

   Cardiology

   Dermatology

   Endocrinology

   Fertility

   Gastroenterology

   Gynecology

   Hematology

   Infections

   Nephrology

   Neurology

   Oncology

   Orthopedics

   Pediatrics

   Pharmacy

   Primary Care

   Psychiatry

   Pulmonology

   Rheumatology

   Surgery

   Urology

   Other Sections

   Membership

   Research Tools

   Medical Tutorials

   Medical Software

 

 Headlines:

 
 

Back to Fertility Articles

Submit your own articles or thesis

Friday 5th November, 2004

 

Scientists have successfully grown stem cells that make sperm, which could lead to treatment of male infertility.

 
 

tellfrnd.gif (30x26 -- 1330 bytes)send to a friend
 
prntfrnd.gif (30x26 -- 1309 bytes)printer friendly version
 
 
 
 
  Related
 
  Sperm enzyme is essential for male fertility  
   
 
     

PHILADELPHIA -- Researchers at the University of Pennsylvania School of Veterinary Medicine have identified the growth factors essential to allow spermatogonial stem cells -- the continually self-renewing cells that produce sperm -- to exist in culture indefinitely. Their findings will be presented this week in the Proceedings of the National Academy of Science online Early Edition.

Spermatagonial stem cells and the hematopoietic stem cells that generate new blood cells are the only types of adult stem cells that can be positively identified using functional assays. Stem cells such as these are called adult stem cells and are not the same as embryonic stem cells. It may also be possible to convert spermatogonial stem cells to totipotent cells, capable of becoming almost any other cell type and similar to embryonic stem cells.

Study details

After being kept in culture for three months, the stem cells restored sperm production, and therefore fertility, in infertile mice.

Hiroshi Kubota, a research assistant professor of cell biology at the Penn Veterinary school, developed the serum-free culture system that enabled him, along with Brinster and researcher Mary R. Avabock, to discover the essential ingredients that will sustain these cells. A step-by-step additive process allowed them to determine that a single growth factor, GDNF, was vital for promoting a signal-pathway that allowed the cells to multiply in culture.

GDNF, the glial cell line-derived neurotrophic factor, was originally identified as a survival factor for neurons in the brain. GDNF was also found to be excreted by the Sertoli cells that surround and support the spermatogonial stem cells in the testes. Once added to the culture, GDNF caused the stem cells to form dense clusters and proliferate continuously.

The Penn researchers then used a GFP marker gene in the cultured stem cells to identify the cells before transplanting them back into infertile mice. These mice then produced offspring that demonstrated the success of the culture system, thanks to the expression of the GFP gene that made the mice glow green under ultraviolet light. As in the mice experiment, genetic changes to sperm stem cells are passed on to the sperm, and, eventually, to any offspring produced from those sperm.

advertisement.gif (61x7 -- 0 bytes)
 

Are you a doctor or a nurse?

Do you want to join the Doctors Lounge online medical community?

Participate in editorial activities (publish, peer review, edit) and give a helping hand to the largest online community of patients.

Click on the link below to see the requirements:

Doctors Lounge Membership Application


Applications

According to the researchers, this development will have profound consequences for future fertility therapies and provide a source of stem cells that will make it possible to modify genes from males before they are passed to the next generation. While the research was performed in mice, the researchers believe that it is likely applicable to other species, including humans.

"We've demonstrated that a central signaling process allows spermatagonial stem cells to continually renew themselves, essentially becoming immortal," said Ralph L. Brinster, a professor of reproductive physiology at Penn. "For research, this opens up a wonderfully robust diagnostic system for analyzing the function of individual genes. For medicine, it opens up a new chapter in fertility medicine."

Whereas the female germ cell, the egg, stops dividing before birth, the spermatogonial stem cells continue to divide throughout life. According to Brinster, it is possible to modify the male germ line between generations by manipulating the spermatogonial stem cells in culture.

"If each parent in a couple carries a similar defective recessive gene for a disease, for example, it should be possible in the future to harvest the male spermatogenic stem cells, correct the gene in culture and implant the stem cells back into the male to produce normal sperm," Brinster said. "The couple could then conceive a healthy child."

Likewise, the ability to culture spermatogonial stem cells indefinitely allows for the possibility to create sperm in vitro, that is, without implanting the stem cells in a recipient male. The technology could be useful for correcting some types of infertility in which the testicular environment is defective.

"The identification of the exogenous factors that allow these stem cells to proliferate in culture establishes the foundation to study the basic biology of spermatogonial stem cells," Kubota said.

Freezing sperm stem cells could also preserve them indefinitely. This may allow men to save their sperm stem cells for future use, which could help men facing chemotherapy preserve their fertility. Currently, men facing infertility from chemotherapy can store their sperm before treatment. However, the pregnancy success rate for frozen sperm is less than 50%.

Funding for the research came from the National Institute of Child Health and Human Development of the National Institutes of Health, the Commonwealth and General Assembly of Pennsylvania and the Robert J. Kleberg Jr. and Helen C. Kleberg Foundation.

Sources

SOURCES: Kubota, H. Proceedings of the National Academy of Sciences, online edition. News release, National Institutes of Health.

Author: [neurology/articles/alzheimer_drug/includes/author.htm]
 

 advertisement.gif (61x7 -- 0 bytes)

 

 



We subscribe to the HONcode principles of the HON Foundation. Click to verify.
We subscribe to the HONcode principles. Verify here

Privacy Statement | Terms & Conditions | Editorial Board | About us
Copyright 2001-2012 DoctorsLounge. All rights reserved.